These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 9380038

  • 1. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT, Riley AM, Lindley CJ, Jenkins DJ, Westwick J, Potter BV.
    Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
    [Abstract] [Full Text] [Related]

  • 2. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA, Erneux C, Primrose WU, Gigg R, Nahorski SR.
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [Abstract] [Full Text] [Related]

  • 3. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT, Bullock AJ, Lindley CJ, Mills SJ, Riley AM, Potter BV, Westwick J.
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [Abstract] [Full Text] [Related]

  • 4. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.
    Marchant JS, Beecroft MD, Riley AM, Jenkins DJ, Marwood RD, Taylor CW, Potter BV.
    Biochemistry; 1997 Oct 21; 36(42):12780-90. PubMed ID: 9335535
    [Abstract] [Full Text] [Related]

  • 5. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA, Challiss RA, Traynor JR, Fauq AH, Ognayanov VI, Kozikowski AP, Nahorski SR.
    J Biol Chem; 1994 Oct 28; 269(43):26815-21. PubMed ID: 7929418
    [Abstract] [Full Text] [Related]

  • 6. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA, Fauq A, Kozikowski AP, Nahorski SR.
    FEBS Lett; 1997 Feb 03; 402(2-3):241-5. PubMed ID: 9037203
    [Abstract] [Full Text] [Related]

  • 7. Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of the inositol 1,4,5-trisphosphate receptor.
    Takahashi M, Tanzawa K, Takahashi S.
    J Biol Chem; 1994 Jan 07; 269(1):369-72. PubMed ID: 8276820
    [Abstract] [Full Text] [Related]

  • 8. Molecular recognition of adenophostin, a very potent Ca2+ inducer, at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Hotoda H, Murayama K, Miyamoto S, Iwata Y, Takahashi M, Kawase Y, Tanzawa K, Kaneko M.
    Biochemistry; 1999 Jul 20; 38(29):9234-41. PubMed ID: 10413497
    [Abstract] [Full Text] [Related]

  • 9. Acyclophostin: a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy.
    Beecroft MD, Marchant JS, Riley AM, Van Straten NC, Van der Marel GA, Van Boom JH, Potter BV, Taylor CW.
    Mol Pharmacol; 1999 Jan 20; 55(1):109-17. PubMed ID: 9882704
    [Abstract] [Full Text] [Related]

  • 10. Evidence for the involvement of a small subregion of the endoplasmic reticulum in the inositol trisphosphate receptor-induced activation of Ca2+ inflow in rat hepatocytes.
    Gregory RB, Wilcox RA, Berven LA, van Straten NC, van der Marel GA, van Boom JH, Barritt GJ.
    Biochem J; 1999 Jul 15; 341 ( Pt 2)(Pt 2):401-8. PubMed ID: 10393099
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group.
    Schäfer R, Nehls-Sahabandu M, Grabowsky B, Dehlinger-Kremer M, Schulz I, Mayr GW.
    Biochem J; 1990 Dec 15; 272(3):817-25. PubMed ID: 2176480
    [Abstract] [Full Text] [Related]

  • 12. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA, Safrany ST, Lampe D, Mills SJ, Nahorski SR, Potter BV.
    Eur J Biochem; 1994 Jul 01; 223(1):115-24. PubMed ID: 8033885
    [Abstract] [Full Text] [Related]

  • 13. Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes.
    Gregory RB, Hughes R, Riley AM, Potter BV, Wilcox RA, Barritt GJ.
    Biochem J; 2004 Jul 15; 381(Pt 2):519-26. PubMed ID: 15169542
    [Abstract] [Full Text] [Related]

  • 14. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site.
    Lu PJ, Gou DM, Shieh WR, Chen CS.
    Biochemistry; 1994 Sep 27; 33(38):11586-97. PubMed ID: 7918372
    [Abstract] [Full Text] [Related]

  • 15. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST, Wojcikiewicz RJ, Strupish J, Nahorski SR, Dubreuil D, Cleophax J, Gero SD, Potter BV.
    FEBS Lett; 1991 Jan 28; 278(2):252-6. PubMed ID: 1846823
    [Abstract] [Full Text] [Related]

  • 16. Binding and activity of the nine possible regioisomers of myo-inositol tetrakisphosphate at the inositol 1,4,5-trisphosphate receptor.
    Burford NT, Nahorski SR, Chung SK, Chang YT, Wilcox RA.
    Cell Calcium; 1997 Apr 28; 21(4):301-10. PubMed ID: 9160166
    [Abstract] [Full Text] [Related]

  • 17. Adenophostin A can stimulate Ca2+ influx without depleting the inositol 1,4,5-trisphosphate-sensitive Ca2+ stores in the Xenopus oocyte.
    DeLisle S, Marksberry EW, Bonnett C, Jenkins DJ, Potter BV, Takahashi M, Tanzawa K.
    J Biol Chem; 1997 Apr 11; 272(15):9956-61. PubMed ID: 9092535
    [Abstract] [Full Text] [Related]

  • 18. myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Murphy CT, Riley AM, Mills SJ, Lindley CJ, Potter BV, Westwick J.
    Mol Pharmacol; 2000 Mar 11; 57(3):595-601. PubMed ID: 10692501
    [Abstract] [Full Text] [Related]

  • 19. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M, Narumoto N, Watanabe Y, Kanematsu T, Koga T, Ozaki S.
    Mol Pharmacol; 1994 Feb 11; 45(2):271-6. PubMed ID: 8114676
    [Abstract] [Full Text] [Related]

  • 20. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate.
    Wilcox RA, Whitham EM, Liu C, Potter BV, Nahorski SR.
    FEBS Lett; 1993 Dec 27; 336(2):267-71. PubMed ID: 8262243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.